Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @BioNTech_Group
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @BioNTech_Group
-
We are excited to announce that we have entered into a definitive
#merger#agreement under which we will acquire@neon_tx to strengthen our#global#leadership position in T#celltherapies. Read more here: https://bit.ly/2TuguE7#immunooncology#cancerimmunotherapy#oncologypic.twitter.com/riQEgBA2u2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Yesterday our CBO & CCO Sean Marett discussed the future of cell & gene therapies at the
#BiotechShowcase highlighting the importance of manufacturing of#cell-based therapies.That is why we are in the process of further expanding our in-house capabilities in the next years$BNTXpic.twitter.com/yiKWNYuNxc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are excited to announce the
#appointment of Ryan Richardson as Chief Strategy Officer and Managing Director. Ryan will support us in our long-term#growth#strategy to become a#leading#global#biotech company. Read the full PR here: https://bit.ly/3a4zNcX pic.twitter.com/6Mw2owmF9G
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meet Sean Marett, our CBO & CCO at the
#BiotechShowcase on January 14, 2020, in San Francisco, where he will discuss the future of#cell &#gene#therapies on a panel at 8.00 am PT#CART#JPM20 https://bit.ly/39VT9AW pic.twitter.com/7DsBM3jtG0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Interested in European biotech companies? We are happy to be named one of the 20 European
#biotech companies to follow this year.@Labiotech_eu consulted with experts to identify the companies across all areas of biotech. #2020 Check out the entire list:https://www.labiotech.eu/tops/european-biotech-companies-2020/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Preclinical PoC data on our first solid
#tumor#CART program BNT211 were published in the current issue of@sciencemagazine. Read the full paper on how we aim to overcome the existing hurdles and create an efficient approach with our CARVac technology here https://bit.ly/2MP0BE1 pic.twitter.com/f2sDmhr6mC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We announced a €50M financing from
@EIB to advance R&D, market access and manufacturing development of our most advanced treatments under development.#junkerplan#Europe#innovationpic.twitter.com/l2peDRfOE2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are on top in
@GENbio’s ranking of the 10 best immuno-oncology start-ups of 2019. Thanks@AlexWestchester for including us!https://twitter.com/GENbio/status/1201681220263960577 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Read more about our
#CMO Özlem Türeci in@endpts special report on 20 extraordinary#women in#biopharma. Özlem is one of many women at#BioNTech who support our vision.https://twitter.com/endpts/status/1193910381548322817 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Proud to be named company of the year at this year’s
@LSXLeaders#lifestarawards, big thanks to the BioNTech family!https://twitter.com/LSXLeaders/status/1196915814903025669 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congrats to our CEO Ugur on receiving the
#lifestaraward in the category private CEO of the year from@LSXLeadershttps://twitter.com/LSXLeaders/status/1196917622216044545 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today we announced our third quarter financial report, the first as a public company, detailing our progress for the year to date. Looking for the full report? Click here: https://bit.ly/32JgLnr
#individualizedmedicine#cancerpic.twitter.com/R4pefmSBr4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioNTech SE proslijedio/la je Tweet
"We're a Germany company. We think long-term." Sean Marett
@BioNTech_Group#BIOEuropeHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioNTech SE proslijedio/la je Tweet
“Anyone who tells you that building a biotech company in Europe is easy is mistaken.” — Sean Marett, COO of
@BioNTech_Group at the panel: "Funding Trends and How to Break Them"#BIOEuropepic.twitter.com/WceMuQMECR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are excited to announce the launch of our new website. We believe that our approach to treating cancer is unique. So is BioNTech as a company. Hence, our employees represent the face(s) of our new website. Take a look at: https://biontech.de/ pic.twitter.com/oezgTCJkhY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are proud to announce that BioNTech is now officially
@Nasdaq. This is an important step on our journey to individualize cancer medicine globally.#BioNTechIPO$BNTXpic.twitter.com/2ACCqVnfCP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It’s official! First day of trading begins for
$BNTX on Thursday, October 10th at 9:30am ET (3:30pm CET)#BioNTechIPOhttps://twitter.com/Nasdaq/status/1182292248140099585 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are excited to announce the closing of a $325M
#SeriesB round, one of the largest private#financing events for a#European#biotech company to advance our#individualized#cancer medicine pipeline.#DigitalTransformation#AI See full press release here:https://bit.ly/2XwBsW2 pic.twitter.com/5Fvspp4Wyv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioNTech SE proslijedio/la je Tweet
Fireside chat with VP Business Alliances Holger Kissel of
@BioNTech_Group - "How to close a high-value drug development deal?"#InsiderDay#biotechpic.twitter.com/kPm16e5mRQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BioNTech CBO/CCO, Sean Marett, is featured on our collaborator's
@Roche website discussing advances in the#cancer-immunity cycle. Click here to read about how together we are individualizing#cancercare with innovative vaccines & technology: https://bit.ly/2ET1YxD pic.twitter.com/sq2lDK1fyH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.